Literature DB >> 22752457

The role of CXC chemokines and their receptors in the progression and treatment of tumors.

Qingchao Zhu1, Xiaodong Han, Jiayuan Peng, Huanlong Qin, Yu Wang.   

Abstract

Chemokines are a class of functional chemotactic peptides that contribute to a number of tumor-related processes. They are functionally defined as soluble factors that are able to control the directional migration of leukocytes, in particular, during infection and inflammation. It appears, however, that the biological effects mediated by chemokines are far more complex, and virtually all cells, including many tumor cell types, can express chemokines and chemokine receptors. A growing body of evidence indicates that they also contribute to a number of tumor-related processes, such as tumor cell growth, angiogenesis/angiostasis, local invasion, and mediate organ-specific metastases of cancer. The CXC chemokine class is a subfamily of a large family of chemokines. During the occurrence and development of tumor cells, this chemokine class is often accompanied by a series of molecular and biological changes. The CXC chemokine subfamily is closely related to the body's immune response to tumors and biological behaviors of tumors. In this paper, CXC chemokines and their role in the progression and treatment of tumors will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752457     DOI: 10.1007/s10735-012-9435-x

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  114 in total

1.  Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.

Authors:  I Narvaiza; G Mazzolini; M Barajas; M Duarte; M Zaratiegui; C Qian; I Melero; J Prieto
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.

Authors:  Sunil K Manna; Govindarajan T Ramesh
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

3.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Authors:  Roderick J Phillips; Marie D Burdick; Marin Lutz; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

4.  Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.

Authors:  R Bordoni; R Fine; D Murray; A Richmond
Journal:  J Cell Biochem       Date:  1990-12       Impact factor: 4.429

5.  Direct inhibition of human acute myeloid leukemia cell growth by IL-12.

Authors:  Elisa Ferretti; Emma Di Carlo; Claudia Cocco; Domenico Ribatti; Carlo Sorrentino; Emanuela Ognio; Daniela Montagna; Vito Pistoia; Irma Airoldi
Journal:  Immunol Lett       Date:  2010-08-10       Impact factor: 3.685

Review 6.  Chemokines in cancer.

Authors:  Alain P Vicari; Christophe Caux
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

7.  Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8.

Authors:  Ruth Schruefer; Nicola Lutze; Jürgen Schymeinsky; Barbara Walzog
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10-21       Impact factor: 4.733

Review 8.  The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.

Authors:  Jianhua Wang; Robert Loberg; Russell S Taichman
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

Review 9.  Chemokines: key players in cancer.

Authors:  M Arya; H R H Patel; M Williamson
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

Review 10.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

View more
  29 in total

1.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

2.  Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells.

Authors:  Qinglin Li; Jixiang Xia; Yuan Yao; Da-Wei Gong; Hongfei Shi; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2013-09-04       Impact factor: 4.872

Review 3.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

4.  Molecular response of the axillary lymph node microenvironment to metastatic colonization.

Authors:  Allyson L Valente; Jennifer L Kane; Darrell L Ellsworth; Craig D Shriver; Rachel E Ellsworth
Journal:  Clin Exp Metastasis       Date:  2014-04-01       Impact factor: 5.150

5.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

6.  Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Clin Exp Metastasis       Date:  2015-03-24       Impact factor: 5.150

7.  Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis.

Authors:  Juan Li; Geping Yin; Ming Chen; Shujun Yang; Aifang Wu; Jing Liang; Zheng Yuan
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

Review 8.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 9.  Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.

Authors:  Ismael Ghanem; Maria E Riveiro; Valerie Paradis; Sandrine Faivre; Paula M Vázquez de Parga; Eric Raymond
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

10.  Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.

Authors:  Kai Li; Zhengpeng Zhu; Jin Luo; Jingyi Fang; Huanhuan Zhou; Min Hu; Ninu Maskey; Guifang Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.